Nevada
|
82-0490737
|
(State
or other jurisdiction of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
to
be Registered
|
|
Amount
to be
Registered
(1)
|
|
Proposed
Maximum
Offering
Price Per
Share
(2)
|
|
Proposed
Maximum
Aggregate
Offering
Price (2)
|
|
Amount
of
Registration
Fee
(2)
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Common
Stock , $.001 par value
|
|
|
2,075,000
|
$
|
.03105
|
|
$
|
64,428.75
|
|
$
|
1.98
|
|
|
(1)
|
Issuable
pursuant to the Compensation Agreement between Grant Life Sciences,
Inc.
and Gregory Sichenzia, dated as of May 9, 2007.
|
|
(2)
|
Estimated
solely for purposes of calculating the registration fee in accordance
with
Rule 457(c) under the Securities Act of 1933, using the average of
the
high and low price of the Common Stock as reported on May 4, 2007
on the
OTC Electronic Bulletin Board, which was $0.034 and $0.0281,
respectively.
|
· |
Reference
is made the Registrant’s current report on Form 8-K/A as filed with the
SEC on April 30, 2007, which is hereby incorporated by
reference.
|
· |
Reference
is made the Registrant’s current report on Form 8-K as filed with the SEC
on April 23, 2007, which is hereby incorporated by
reference.
|
· |
Reference
is made the Registrant’s current report on Form 8-K as filed with the SEC
on April 13, 2007, which is hereby incorporated by
reference.
|
· |
Reference
is made to the Registrant’s annual report on Form 10-KSB for the year
ended December 31, 2006, as filed with the SEC on April 2, 2007,
which is
hereby incorporated by reference.
|
· |
Reference
is made to the description of the Registrant’s common stock as contained
in its Registration Statement on Form SB-2, as filed with the SEC
on
October 3, 2006, together with all amendments or reports filed for
the
purpose of updating such
description.
|
Exhibit
No.
|
|
Description
|
|
|
|
5.1
|
|
Opinion
of Sichenzia Ross Friedman Ference l, LLP
|
|
|
|
10.2
|
|
Compensation
Agreement
|
|
|
|
23.1
|
|
Consent
of Singer Lewak Greenbaum & Goldstein LLP., CPA’s.
|
|
|
|
23.2
|
|
Consent
of Sichenzia Ross Friedman Ference, LLP (included in its opinion
filed as
Exhibit 5.1)
|
|
GRANT
LIFE SCIENCES, INC.
|
|
|
|
|
|
|
|
|
By:
|
/s/
Hun-Chi Lin
|
|
|
Hun-Chi
Lin
President
and Director (principal executive
officer)
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/
Stan Yakatan
|
|
Chairman
of the Board of Directors
|
|
May
11, 2007
|
Stan
Yakatan
|
|
|
|
|
|
|
|
|
|
/s/
Hun-Chi Lin
|
|
President,
Chief Scientific Officer and Director
(principal
executive officer)
|
|
May
11, 2007
|
Hun-Chi
Lin
|
|
|
|
|
|
|
|
|
|
/s/
Doyle R. Judd
|
|
Chief
Financial Officer (principal financial
officer
and chief accounting officer)
|
|
May
11, 2007
|
Doyle
R. Judd
|
|
|
|
|
|
|
|
|
|
/s/
Michael Ahlin
|
|
Vice
President and Director
|
|
May
11, 2007
|
Michael Ahlin |
|
|
|
|
|
/s/
Jack Levine
|
|
Director
|
|
May
11, 2007
|
Jack
Levine
|